Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Palte

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of the American Chemical Society|March 10, 2012
Interaction of nucleic acids with the glycocalyxMichael J Palte, Ronald T Raines
Chemical Science|March 6, 2014
Organocatalytic Conversion of Cellulose into a Platform ChemicalBenjamin R Caes, Michael J Palte, Ronald T Raines
Journal of the American Chemical Society|February 7, 2012
Boronate-mediated biologic deliveryGregory A Ellis, Michael J Palte, Ronald T Raines
The Journal of Organic Chemistry|January 3, 2019
Catalysis of Hydrogen-Deuterium Exchange Reactions by 4-Substituted Proline DerivativesEddie L Myers, Michael J Palte, Ronald T Raines
Journal of the American Chemical Society|February 23, 2012
A potent, versatile disulfide-reducing agent from aspartic acidJohn C Lukesh, Michael J Palte, Ronald T Raines
The Journal of Applied Laboratory Medicine|October 23, 2019
A Rapid Dilute-and-Shoot UPLC-MS/MS Assay to Simultaneously Measure 37 Drugs and Related Metabolites in Human Urine for Use in Clinical Pain ManagementJayme L Dahlin, Michael J Palte, John LaMacchia, et al.
ACS Medicinal Chemistry Letters|May 22, 2012
Ribonuclease-Activated Cancer ProdrugGregory A Ellis, Nicholas A McGrath, Michael J Palte, et al.
Chemmedchem|July 19, 2012
Ribonucleoside 3'-phosphates as pro-moieties for an orally administered drugMichael J Palte, Amy K F Davis, Nicholas A McGrath, et al.
Journal of the American Chemical Society|October 23, 2018
Sub-picomolar Inhibition of HIV-1 Protease with a Boronic AcidIan W Windsor, Michael J Palte, John C Lukesh, et al.
Advances in Therapy|September 21, 2019
Improving the Gastrointestinal Tolerability of Fumaric Acid Esters: Early Findings on Gastrointestinal Events with Diroximel Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis from the Phase 3, Open-Label EVOLVE-MS-1 StudyMichael J Palte, Angela Wehr, Mark Tawa, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of the American Chemical Society|March 10, 2012
Interaction of nucleic acids with the glycocalyxMichael J Palte, Ronald T Raines
Chemical Science|March 6, 2014
Organocatalytic Conversion of Cellulose into a Platform ChemicalBenjamin R Caes, Michael J Palte, Ronald T Raines
Journal of the American Chemical Society|February 7, 2012
Boronate-mediated biologic deliveryGregory A Ellis, Michael J Palte, Ronald T Raines
The Journal of Organic Chemistry|January 3, 2019
Catalysis of Hydrogen-Deuterium Exchange Reactions by 4-Substituted Proline DerivativesEddie L Myers, Michael J Palte, Ronald T Raines
Journal of the American Chemical Society|February 23, 2012
A potent, versatile disulfide-reducing agent from aspartic acidJohn C Lukesh, Michael J Palte, Ronald T Raines
The Journal of Applied Laboratory Medicine|October 23, 2019
A Rapid Dilute-and-Shoot UPLC-MS/MS Assay to Simultaneously Measure 37 Drugs and Related Metabolites in Human Urine for Use in Clinical Pain ManagementJayme L Dahlin, Michael J Palte, John LaMacchia, et al.
ACS Medicinal Chemistry Letters|May 22, 2012
Ribonuclease-Activated Cancer ProdrugGregory A Ellis, Nicholas A McGrath, Michael J Palte, et al.
Chemmedchem|July 19, 2012
Ribonucleoside 3'-phosphates as pro-moieties for an orally administered drugMichael J Palte, Amy K F Davis, Nicholas A McGrath, et al.
Journal of the American Chemical Society|October 23, 2018
Sub-picomolar Inhibition of HIV-1 Protease with a Boronic AcidIan W Windsor, Michael J Palte, John C Lukesh, et al.
Advances in Therapy|September 21, 2019
Improving the Gastrointestinal Tolerability of Fumaric Acid Esters: Early Findings on Gastrointestinal Events with Diroximel Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis from the Phase 3, Open-Label EVOLVE-MS-1 StudyMichael J Palte, Angela Wehr, Mark Tawa, et al.
Pageof 2